ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Other Financing Activities

Financing cash flows not reported separately.

No reported Other Financing Activities figures are available to summarize.

Other Financing Activities history

Currency unavailable · from the cash flow

No Other Financing Activities data reported for this period type.

Other Financing Activities vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Other Financing Activities for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PRMEPrime Medicine, Inc.LTM Mar 2026$151.51M USD+200.4%—3755.9%
RNAAtrium Therapeutics, Inc.FY2025$42.57M USD——228.7%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$14.23M USD-515.6%—31.4%
MGTXMeiraGTx Holdings plcLTM Mar 2026$5.95M USD+24.7%-14.2%7.5%
WVEWave Life Sciences Ltd.LTM Mar 2026$3.07M USD-84.7%—4.3%
BNTCBenitec Biopharma Inc.LTM Mar 2026$178.7K USD-82.2%——
PRQRProQR Therapeutics N.V.LTM Mar 2026€5.85K EUR-100.0%+30.3%0.0%
STOKStoke Therapeutics, Inc.LTM Mar 2026$0 USD-100.0%—0.0%
SLNSilence Therapeutics plcLTM Mar 2026$0 USD——0.0%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-84.7%+8.0%5.9%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.